These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25918138)

  • 61. Metabolic pathways of Pseudomonas aeruginosa involved in competition with respiratory bacterial pathogens.
    Beaume M; Köhler T; Fontana T; Tognon M; Renzoni A; van Delden C
    Front Microbiol; 2015; 6():321. PubMed ID: 25954256
    [TBL] [Abstract][Full Text] [Related]  

  • 62. RND-type drug efflux pumps from Gram-negative bacteria: molecular mechanism and inhibition.
    Venter H; Mowla R; Ohene-Agyei T; Ma S
    Front Microbiol; 2015; 6():377. PubMed ID: 25972857
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Agents that inhibit bacterial biofilm formation.
    Rabin N; Zheng Y; Opoku-Temeng C; Du Y; Bonsu E; Sintim HO
    Future Med Chem; 2015; 7(5):647-71. PubMed ID: 25921403
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Microfluidic wound model for studying the behaviors of Pseudomonas aeruginosa in polymicrobial biofilms.
    Wright E; Neethirajan S; Weng X
    Biotechnol Bioeng; 2015 Nov; 112(11):2351-9. PubMed ID: 25994926
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Links between Anr and Quorum Sensing in Pseudomonas aeruginosa Biofilms.
    Hammond JH; Dolben EF; Smith TJ; Bhuju S; Hogan DA
    J Bacteriol; 2015 Sep; 197(17):2810-20. PubMed ID: 26078448
    [TBL] [Abstract][Full Text] [Related]  

  • 66. C-di-GMP regulates Pseudomonas aeruginosa stress response to tellurite during both planktonic and biofilm modes of growth.
    Chua SL; Sivakumar K; Rybtke M; Yuan M; Andersen JB; Nielsen TE; Givskov M; Tolker-Nielsen T; Cao B; Kjelleberg S; Yang L
    Sci Rep; 2015 May; 5():10052. PubMed ID: 25992876
    [TBL] [Abstract][Full Text] [Related]  

  • 67. In Vivo Efficacy of Antimicrobials against Biofilm-Producing Pseudomonas aeruginosa.
    Pawar V; Komor U; Kasnitz N; Bielecki P; Pils MC; Gocht B; Moter A; Rohde M; Weiss S; Häussler S
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4974-81. PubMed ID: 26055372
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Presence of Pseudomonas aeruginosa influences biofilm formation and surface protein expression of Staphylococcus aureus.
    Kumar A; Ting YP
    Environ Microbiol; 2015 Nov; 17(11):4459-68. PubMed ID: 25925222
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Novel inhaled combined antibiotic formulations in the treatment of Pseudomonas aeruginosa airways infections in cystic fibrosis.
    Antoniu S
    Expert Rev Anti Infect Ther; 2015 Jul; 13(7):897-905. PubMed ID: 25921312
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Division of Labor in Biofilms: the Ecology of Cell Differentiation.
    van Gestel J; Vlamakis H; Kolter R
    Microbiol Spectr; 2015 Apr; 3(2):MB-0002-2014. PubMed ID: 26104716
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A novel regulator PA5022 (aefA) is involved in swimming motility, biofilm formation and elastase activity of Pseudomonas aeruginosa.
    Li Y; Bai F; Xia H; Zhuang L; Xu H; Jin Y; Zhang X; Bai Y; Qiao M
    Microbiol Res; 2015 Jul; 176():14-20. PubMed ID: 26070688
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Identification of outer membrane Porin D as a vitronectin-binding factor in cystic fibrosis clinical isolates of Pseudomonas aeruginosa.
    Paulsson M; Singh B; Al-Jubair T; Su YC; Høiby N; Riesbeck K
    J Cyst Fibros; 2015 Sep; 14(5):600-7. PubMed ID: 26047937
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Trigonella foenum-graceum (Seed) Extract Interferes with Quorum Sensing Regulated Traits and Biofilm Formation in the Strains of Pseudomonas aeruginosa and Aeromonas hydrophila.
    Husain FM; Ahmad I; Khan MS; Al-Shabib NA
    Evid Based Complement Alternat Med; 2015; 2015():879540. PubMed ID: 26000026
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effect of superabsorbent dressings in a 3D acellular tissue model of Pseudomonas aeruginosa biofilm.
    Larkö E; Persson A; Blom K
    J Wound Care; 2015 May; 24(5):204, 206-10. PubMed ID: 25970757
    [TBL] [Abstract][Full Text] [Related]  

  • 75. In vitro approach to study the synergistic effects of tobramycin and clarithromycin against Pseudomonas aeruginosa biofilms using prokaryotic or eukaryotic culture media.
    Thellin O; Zorzi W; Jolois O; Elmoualij B; Duysens G; Cahay B; Streel B; Charif M; Bastin R; Heinen E; Quatresooz P
    Int J Antimicrob Agents; 2015 Jul; 46(1):33-8. PubMed ID: 25963337
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mutations associated with reduced surotomycin susceptibility in Clostridium difficile and Enterococcus species.
    Adams HM; Li X; Mascio C; Chesnel L; Palmer KL
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4139-47. PubMed ID: 25941217
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Biofilm and Planktonic Antibiotic Resistance in Patients With Acute Exacerbation of Chronic Rhinosinusitis.
    Sabino HAC; Valera FCP; Santos DV; Fantucci MZ; Titoneli CC; Martinez R; Anselmo-Lima WT; Tamashiro E
    Front Cell Infect Microbiol; 2021; 11():813076. PubMed ID: 35111699
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Overcoming Challenges to Make Bacteriophage Therapy Standard Clinical Treatment Practice for Cystic Fibrosis.
    Ng RN; Tai AS; Chang BJ; Stick SM; Kicic A
    Front Microbiol; 2020; 11():593988. PubMed ID: 33505366
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Bacterial persisters in long-term infection: Emergence and fitness in a complex host environment.
    Bartell JA; Cameron DR; Mojsoska B; Haagensen JAJ; Pressler T; Sommer LM; Lewis K; Molin S; Johansen HK
    PLoS Pathog; 2020 Dec; 16(12):e1009112. PubMed ID: 33315938
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.